menu
    • menu

    Company profile for Jiangsu Simcere Pharmaceutical

    NEW Drugs in Dev: 54
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are rapidly transitioning to an innovation and R&D-driven pharmaceutical company, leveraging our leading manufacturing and commercial capabilities to achieve our mission of “providing today’s patients with medicines of the future” . We have established three R&D centers in Nanjing, Shanghai and Boston, respectively. With the approval of the Ministry of Science and Technology, we have also established a national key la...
    We are rapidly transitioning to an innovation and R&D-driven pharmaceutical company, leveraging our leading manufacturing and commercial capabilities to achieve our mission of “providing today’s patients with medicines of the future” . We have established three R&D centers in Nanjing, Shanghai and Boston, respectively. With the approval of the Ministry of Science and Technology, we have also established a national key laboratory of translational medicine and innovative pharmaceuticals .

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jiangsu Simcere PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    699-18 Xuanwu Avenue Nanjing
    Telephone
    Telephone
    025-85566666
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.simcere.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nextcure And Simcere Zaiming Start Dose Optimization For SIM0505
    Nextcure And Simcere Zaiming Start Dose Optimization For SIM0505

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286574/0/en/nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Nextcure And Simcere To Present SIM0505 Phase 1 Data At ASCO 2026
    Nextcure And Simcere To Present SIM0505 Phase 1 Data At ASCO 2026

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7198170

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    NextCure & Simcere SIM0505 CDH6 ADC Abstract Accepted at ASCO
    NextCure & Simcere SIM0505 CDH6 ADC Abstract Accepted at ASCO

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3266022/0/en/NextCure-and-Simcere-s-SIM0505-CDH6-ADC-Abstract-Accepted-for-ASCO-2026.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Boehringer in Deal with China's Simcere to License IBD Drug
    Boehringer in Deal with China's Simcere to License IBD Drug

    28 Jan 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/boehringer-ingelheim-deal-with-chinas-simcere-pharma-license-ibd-drug-candidate-2026-01-27/

    REUTERS
    28 Jan 2026
    Share Share
    Ipsen's ADC push leads to $1B deal for preclinical Simcere drug
    Ipsen's ADC push leads to $1B deal for preclinical Simcere drug

    27 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/22/3208932/0/en/Ipsen-expands-early-development-pipeline-with-Simcere-Zaiming-s-innovative-antibody-drug-conjugate.html

    GLOBENEWSWIRE
    27 Dec 2025
    Share Share
    Simcere's SIM0278 Enters Phase II Trial For IL-2 Mutant Fusion
    Simcere's SIM0278 Enters Phase II Trial For IL-2 Mutant Fusion

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/simceres-il-2-mutant-fusion-protein-sim0278-entered-phase-ii-clinical-trial-stage-302609998.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Simcere Pharmaceutical and get a quotation

    Simcere Pharmaceutical is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find Iguratimod bulk with JDMF offered by Simcere Pharmaceutical

    Find Dioctahedral smectite bulk offered by Simcere Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search